NO892271L - Fremgangsmaate for fremstilling av bicykliske carboxamider. - Google Patents
Fremgangsmaate for fremstilling av bicykliske carboxamider.Info
- Publication number
- NO892271L NO892271L NO89892271A NO892271A NO892271L NO 892271 L NO892271 L NO 892271L NO 89892271 A NO89892271 A NO 89892271A NO 892271 A NO892271 A NO 892271A NO 892271 L NO892271 L NO 892271L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- cycloalkyl
- alkenyl
- group
- substituted
- Prior art date
Links
- 150000003857 carboxamides Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 4
- 125000003342 alkenyl group Chemical group 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- -1 hydrazinocarbonyl group Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/96—Spiro-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Detergent Compositions (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Nye forbindelser av generell. formel I. hvori. A og B kan være like eller forskjel-lige og betegne et hydrogenatom,. en alkyl-, alkenyl-, alkynyl-,. benzyl- eller cykloalkylgruppe,. Rbetegner et -hydrogenatom, en. alkyl-, alkenyl- eller cykloalkylgruppe ,. R 2 betegner et hydrogenatom, en. alkyl-, alkenyl-, cykloalkyl-,. alkylcarbonyl-, alkoxycarbonyl-,. aminocarbonyl- eller hydrazino-carbonylgruppe, eller hvor og. Rsammen med C-atomet, til. hvilket de er bundet, danner en. cykloalkylring,. n betegner 0 eller 1,. X betegner en binding eller en. alkylengruppe,. Rbetegner en aromatisk hetero-cyklisk, substituert eller usubstituert 5- eller 6-ring, hvorved 5- eller 6-ringen kan være kondensert med en fenylring eller en ytterligere aromatisk 5-eller 6-ring til en bicyklisk for-bindelse som kan være substituert med alkyl-, alkoxy-, alkoxycarbonyl-, carboxyl-, alkylmercapto-, hydroxy-, nitro-, amino-, halogen-eller cyangruppen, eller hvor R 3 betegner en substituert eller usubstituert fenyl- eller nafthyl-rest,. utviser terapeutisk aktivitet. Frem-stilling av forbindelsene er beskrevet.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3818830A DE3818830A1 (de) | 1988-06-03 | 1988-06-03 | Bicyclische carboxamide, verfahren zu ihrer herstellung, deren vorstufen, und diese verbindungen enthaltende arzneimittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO892271D0 NO892271D0 (no) | 1989-06-02 |
| NO892271L true NO892271L (no) | 1989-12-04 |
Family
ID=6355728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO89892271A NO892271L (no) | 1988-06-03 | 1989-06-02 | Fremgangsmaate for fremstilling av bicykliske carboxamider. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5019587A (no) |
| EP (1) | EP0344634B1 (no) |
| JP (1) | JPH0225464A (no) |
| KR (1) | KR900000339A (no) |
| CN (1) | CN1038640A (no) |
| AT (1) | ATE103593T1 (no) |
| AU (1) | AU616521B2 (no) |
| DD (1) | DD283809A5 (no) |
| DE (2) | DE3818830A1 (no) |
| DK (1) | DK268789A (no) |
| FI (1) | FI892730A7 (no) |
| HU (1) | HUT53074A (no) |
| IL (1) | IL90447A0 (no) |
| MX (1) | MX16283A (no) |
| NO (1) | NO892271L (no) |
| NZ (1) | NZ229335A (no) |
| PT (1) | PT90744B (no) |
| ZA (1) | ZA894236B (no) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3803775A1 (de) * | 1988-02-09 | 1989-08-17 | Boehringer Mannheim Gmbh | Neue substituierte lactame, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten |
| DE3935514A1 (de) * | 1989-10-25 | 1991-05-02 | Boehringer Mannheim Gmbh | Neue bicyclo-imidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| US5076835A (en) * | 1990-05-31 | 1991-12-31 | America Cyanamid Company | Aryloxyspiroalkylindolinone herbicides |
| BR9200951A (pt) * | 1991-03-21 | 1992-11-17 | Hoffmann La Roche | Compostos, processo para sua producao,preparacoes farmaceuticas e uso |
| FR2708606B1 (fr) * | 1993-07-30 | 1995-10-27 | Sanofi Sa | Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant. |
| FR2740136B1 (fr) * | 1995-10-24 | 1998-01-09 | Sanofi Sa | Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant |
| US7288538B2 (en) | 2003-02-20 | 2007-10-30 | Encysive Pharmaceuticals, Inc. | Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists |
| CA2515780C (en) | 2003-02-20 | 2012-12-11 | Encysive Pharmaceuticals Inc. | Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| JP2010511661A (ja) * | 2006-12-07 | 2010-04-15 | エフ．ホフマン−ラ ロシュ アーゲー | Ｖ１ａ受容体アンタゴニストとしてのスピロ−ピペリジン誘導体 |
| MX2009006454A (es) * | 2006-12-22 | 2009-06-26 | Hoffmann La Roche | Derivados de espiro-piperidina. |
| EP2895476B1 (en) | 2012-09-13 | 2016-06-22 | F.Hoffmann-La Roche Ag | 2-oxo-2,3-dihydro-indoles for the treatment of cns disorders |
| AR101196A1 (es) * | 2014-07-16 | 2016-11-30 | Gruenenthal Gmbh | Compuestos de pirimidina sustituidos |
| AR101198A1 (es) | 2014-07-16 | 2016-11-30 | Gruenenthal Gmbh | Pirimidinas 2,5-sustituidas como inhibidores de pde4b |
| WO2018086703A1 (en) | 2016-11-11 | 2018-05-17 | Bayer Pharma Aktiengesellschaft | Dihydropyridazinones substituted with phenylureas |
| JP2020524718A (ja) * | 2017-06-22 | 2020-08-20 | キュラデブ・ファーマ・リミテッドＣｕｒａｄｅｖ Ｐｈａｒｍａ Ｌｉｍｉｔｅｄ | ヒトｓｔｉｎｇの複素環式小分子調節因子 |
| GB2572526A (en) * | 2017-06-22 | 2019-10-09 | Curadev Pharma Ltd | Heterocyclic small molecule modulators of human STING |
| WO2019149637A1 (en) | 2018-01-31 | 2019-08-08 | Bayer Aktiengesellschaft | Antibody drug conjugates (adcs) with nampt inhibitors |
| IL279526B2 (en) * | 2018-06-22 | 2026-05-01 | Ucl Business Ltd | Compounds for the treatment of alpha-1 antitrypsin-mediated diseases |
| WO2021013693A1 (en) | 2019-07-23 | 2021-01-28 | Bayer Pharma Aktiengesellschaft | Antibody drug conjugates (adcs) with nampt inhibitors |
| AU2024334603A1 (en) | 2023-08-30 | 2026-02-19 | Syngenta Crop Protection Ag | Pesticidally active oxoindole compounds |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI77852C (fi) * | 1981-02-17 | 1989-05-10 | Otsuka Pharma Co Ltd | Foerfarande foer framstaellning av nya, saosom hjaertmediciner anvaendbara substituerade amid- och (maettad heterocykel)karbonylkarbostyrilderivat. |
| FR2584713B1 (fr) * | 1985-07-11 | 1988-09-09 | Roussel Uclaf | Nouveaux derives de l'indole carboxamide, leurs sels, procede et intermediaires de preparation, application a titre de medicaments et compositions les renfermant |
| DK111387A (da) * | 1986-03-05 | 1987-09-06 | Otsuka Pharma Co Ltd | Carbostyrilderivater og salte deraf, laegemiddel indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne |
| US4886809A (en) * | 1986-07-31 | 1989-12-12 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives and salts thereof |
-
1988
- 1988-06-03 DE DE3818830A patent/DE3818830A1/de not_active Withdrawn
-
1989
- 1989-05-26 AT AT89109511T patent/ATE103593T1/de not_active IP Right Cessation
- 1989-05-26 EP EP89109511A patent/EP0344634B1/de not_active Expired - Lifetime
- 1989-05-26 DE DE89109511T patent/DE58907324D1/de not_active Expired - Fee Related
- 1989-05-29 AU AU35283/89A patent/AU616521B2/en not_active Ceased
- 1989-05-29 NZ NZ229335A patent/NZ229335A/xx unknown
- 1989-05-29 IL IL90447A patent/IL90447A0/xx unknown
- 1989-05-30 DD DD89329063A patent/DD283809A5/de not_active IP Right Cessation
- 1989-06-01 MX MX1628389A patent/MX16283A/es unknown
- 1989-06-01 DK DK268789A patent/DK268789A/da not_active Application Discontinuation
- 1989-06-02 PT PT90744A patent/PT90744B/pt not_active IP Right Cessation
- 1989-06-02 FI FI892730A patent/FI892730A7/fi not_active Application Discontinuation
- 1989-06-02 NO NO89892271A patent/NO892271L/no unknown
- 1989-06-02 JP JP1139392A patent/JPH0225464A/ja active Pending
- 1989-06-02 HU HU892835A patent/HUT53074A/hu unknown
- 1989-06-03 KR KR1019890007724A patent/KR900000339A/ko not_active Withdrawn
- 1989-06-03 CN CN89106049A patent/CN1038640A/zh active Pending
- 1989-06-05 US US07/361,090 patent/US5019587A/en not_active Expired - Fee Related
- 1989-06-05 ZA ZA894236A patent/ZA894236B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK268789A (da) | 1989-12-04 |
| CN1038640A (zh) | 1990-01-10 |
| DD283809A5 (de) | 1990-10-24 |
| EP0344634B1 (de) | 1994-03-30 |
| DE58907324D1 (de) | 1994-05-05 |
| NZ229335A (en) | 1990-09-26 |
| PT90744A (pt) | 1989-12-29 |
| NO892271D0 (no) | 1989-06-02 |
| PT90744B (pt) | 1994-10-31 |
| AU3528389A (en) | 1989-12-07 |
| DK268789D0 (da) | 1989-06-01 |
| FI892730A0 (fi) | 1989-06-02 |
| IL90447A0 (en) | 1990-01-18 |
| ATE103593T1 (de) | 1994-04-15 |
| US5019587A (en) | 1991-05-28 |
| DE3818830A1 (de) | 1989-12-14 |
| HUT53074A (en) | 1990-09-28 |
| MX16283A (es) | 1993-11-01 |
| FI892730A7 (fi) | 1989-12-04 |
| ZA894236B (en) | 1990-03-28 |
| JPH0225464A (ja) | 1990-01-26 |
| KR900000339A (ko) | 1990-01-30 |
| EP0344634A1 (de) | 1989-12-06 |
| AU616521B2 (en) | 1991-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG60307B2 (en) | Method for obtaining of substituted two-ring compounds | |
| NO973338L (no) | N-(4-aryl-tiazol-2-yl)-sulfonamid-derivater og deres anvendelse | |
| JPS51143673A (en) | New derivatives of 4-aminopiperidines | |
| AU544374B2 (en) | Substituted 7-imidazolo-amino cepholosporic derivatives | |
| JPS51143674A (en) | New derivatives of 4-oxopiperidines | |
| ATE74269T1 (de) | Zellproliferationsinhibitor. | |
| GB1388652A (en) | 3-acylhydrazonomethyl rifamycin sv | |
| DE3668171D1 (de) | 1-aryl-5-alkoximinoalkylamino-pyrazole. | |
| FI851611A0 (fi) | Heterocykliska aminokomponenter. | |
| AU1745176A (en) | Polymerisates of olefinic nitriles | |
| ES309171A1 (es) | Procedimiento para la preparacion de nuevos compuestos heterociclicos condensados. | |
| FR2479219B1 (no) | ||
| ES552281A0 (es) | Un procedimiento para la preparacion de derivados de homocisteina-tiolactona | |
| EP0245991A3 (en) | Benzothiazoline fungicides | |
| AU5758880A (en) | Oxazoline and thiazoline derivatives | |
| ES409126A1 (es) | Procedimiento para la preparacion de derivados de sales de 2-mercapto-pirido (1,2-b)-1,2,4-tiadiazolio. | |
| JPS5283362A (en) | Synthesis of isoindoline derivative pigment | |
| ES431300A1 (es) | Un procedimiento de preparacion de un derivado de benzoxa- zol. | |
| GB1505859A (en) | Azetidinone derivatives | |
| ES451988A1 (es) | Procedimiento para la preparacion de aminobenzaldehido n- sustituidos. | |
| ES8103748A1 (es) | Procedimiento para la preparacion de 5,6,7,8-tetrahidropira-zolo (3,4-b)(1,5) diazepin-1h,4h-5,7-dionas | |
| SU782319A1 (ru) | 2-Окси-5-бромбензилиденгидразиды дизамещенных гликолевых кислот, обладающие противовоспалительной активностью | |
| JPS5283890A (en) | Heterocyclic compounds | |
| WO1999055156A3 (de) | Verwendung von derivaten des iminotriazols als pflanzenschutzmittel und neue iminotriazole | |
| ES455963A1 (es) | Un procedimiento para la preparacion de compuestos imidazo (1,5-a) (1,4). |